Literature DB >> 6994790

Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.

M Velasco, J Guevara, J Morillo, A Ramírez, A Urbina-Quintana, O Hernández-Pieretti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6994790      PMCID： PMC1429948          DOI： 10.1111/j.1365-2125.1980.tb05846.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Atenolol in hypertension a study of long-term therapy.

Authors:  F J Zacharias; K J Cowen; P F Cuthbertson; T B Johnson; J Prestt; J Thompson; J Vickers; W T Simpson; R Tuson
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  Atenolol and plasma renin concentration in hypertensive patients.

Authors:  A Amery; P Lijnen; R Fagard; T Reybrouck
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  Comparison of propranolol and atenolol in hypertension.

Authors:  F J Zacharias; K J Cowen
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

4.  Relationship between blood level of atenolol and pharmacologic effect.

Authors:  A Amery; J F De Plaen; P Lijnen; J McAinsh; T Reybrouck
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

5.  Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.

Authors:  M Velasco; K O'Malley; N W Robie; J Wells; Z H Israili; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Systolic time intervals in cardiac disease (II).

Authors:  A M Weissler; C L Garrard
Journal:  Mod Concepts Cardiovasc Dis       Date:  1971-02

9.  The gas chromatographic determination of atenolol in biological samples.

Authors:  B Scales; P B Copsey
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

10.  Atenolol in essential hypertension.

Authors:  M G Myers; G R Lewis; J Steiner; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875
View more
  2 in total

1.  Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.

Authors:  J Godbillon; A Gerardin; V A John; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.

Authors:  A Roux; A Le Liboux; B Delhotal; J Gaillot; B Flouvat
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.